Abstract
Nonsteroidal anti‐inflammatory drugs (NSAIDs) like indomethacin alter gut microbiota composition and disrupt intestinal integrity, increasing the risks of inflammatory bowel disease (IBD). Gut barrier function is regulated by a complex crosstalk between different cell types, including epithelial cells and cells from the enteric nervous system (ENS). Human milk oligosaccharides (hMOs), particularly 2′‐fucosyllactose (2′‐FL) and 3‐fucosyllactose (3‐FL), can regulate intestinal barrier function, but their roles in neuroepithelial crosstalk under NSAID stress remain unclear. This study focused on hMOs’ direct epithelial effects to explore their potential in microbiota‐independent effects caused by the NSAID indomethacin. T84 colorectal carcinoma cells were cocultured with SH‐SY5Y neuroblastoma cells in ratios of 29:1 and 14:1. We evaluated the protective role of hMOs in indomethacin‐induced barrier disruption. We found that indomethacin reduced transepithelial electrical resistance (TEER), disrupted F‐actin organization, and decreased tight junction (TJ) protein expression. Pretreatment with 2′‐FL and 3‐FL protected against these effects, particularly in cocultures with a higher nerve cell ratio of 14:1, restoring TEER, F‐actin integrity, and claudin‐1 expression. These findings highlight the therapeutic potential of 2′‐FL and 3‐FL in directly maintaining barrier integrity in intestinal neuroepithelial cocultures during NSAID treatment.

This publication has 49 references indexed in Scilit: